Dedifferentiated chondrosarcomas (DDCS) are aggressive tumors with poor outcomes.
Treatment of localized DDCS is primarily surgical, though most patients present with …

Dedifferentiated chondrosarcoma is an aggressive mesenchymal tumor of the bone, and
novel therapies are needed to improve its clinical outcomes. Patient-derived cell lines are …

This article presents a review of chondrosarcoma variants, with a focus on the extraordinarily
rare variants of chondrosarcoma in which hyaline cartilage is not the dominant feature …

Simple Summary Chondrosarcoma (ChS) is the second most frequently diagnosed
malignant bone tumor of cartilaginous origin and is generally resistant to standard treatment …

Simple Summary Chondrosarcomas are a very heterogeneous group of cartilage-forming
tumors that comprise approximately one-third of all malignant bone tumors. The World …

Conclusion: Chondrosarcoma is responsible for placing a significant burden on pediatric as
well as adult orthopedic oncology. Optimum diagnosis, accurate interpretation of …

We reviewed 74 cases of dedifferentiated central and peripheral chondrosarcoma.
Histologically these tumours consist of an underlying cartilaginous component (either …

Dedifferentiated chondrosarcomas are primary bone tumors characterized by the presence
of both low-grade cartilaginous and high-grade sarcomatous components. The high-grade …

Introduction. Chondrosarcomas are malignant bone tumors that are characterized by the
production of chondroid tissue. Since radiation therapy and chemotherapy have limited …

Aims: De‐differentiated chondrosarcoma is characterized by the presence of two distinct
chondroid and nonchondroid tumour portions. The aim of our study was to investigate the …